Patents by Inventor Gilberto IRAGORRI

Gilberto IRAGORRI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240156843
    Abstract: The disclosure relates to methods for treating brain injuries that include administering to a patient a first dosage of about 100 mg to about 500 mg of cannabidiol (CBD) and administering to the patient, concomitantly with the first dosage, a second dosage of about 1 to about 10 milligrams of Psilocybin.
    Type: Application
    Filed: January 19, 2024
    Publication date: May 16, 2024
    Applicant: ECP Pharma
    Inventors: Nitin ANAND, Michael E. HOFFER, Moiz RANGWALLA, Andy MERA, Gilberto IRAGORRI
  • Patent number: 11911402
    Abstract: The disclosure relates to methods for treating brain injuries that include administering to a patient a first dosage of about 100 mg to about 500 mg of cannabidiol (CBD) and administering to the patient, concomitantly with the first dosage, a second dosage of about 1 to about 10 milligrams of Psilocybin.
    Type: Grant
    Filed: October 12, 2022
    Date of Patent: February 27, 2024
    Assignee: ECP Pharma
    Inventors: Nitin Anand, Michael E. Hoffer, Moiz Rangwalla, Andy Mera, Gilberto Iragorri
  • Publication number: 20230112459
    Abstract: The disclosure relates to methods for treating brain injuries that include administering to a patient a first dosage of about 100 mg to about 500 mg of cannabidiol (CBD) and administering to the patient, concomitantly with the first dosage, a second dosage of about 1 to about 10 milligrams of Psilocybin.
    Type: Application
    Filed: October 12, 2022
    Publication date: April 13, 2023
    Applicant: ECP Pharma
    Inventors: Nitin ANAND, Michael E. HOFFER, Moiz RANGWALLA, Andy MERA, Gilberto IRAGORRI